Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. Neukamm, N. H. Holmedahl, G. Einvik, T. A. Hagve, V. SØyseth, T. Omland (LØrenskog, Hakadal, Oslo, Norway). Cardiac troponin T levels increase overnight in patients with stable chronic obstructive pulmonary disease. Eur Respir J 2013; 42: Suppl. 57, 647

Member's Comments

No comment yet.

Related content which might interest you: High-sensitivity cardiac troponin T is associated with increased mortality in patients with stable chronic obstructive pulmonary disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation Source: Eur Respir J 2008; 31: 563-570 Year: 2008 Increased prevalence of elevated high-sensitivity cardiac troponin T among patients with stable chronic obstructive pulmonary disease Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Increased serum level of apelin in chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Mechanisms of Cardiac arrhythmias in patients with chronic obstructive disease (COPD) Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018 Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Dysregulation of serum miRNA in chronic obstructive pulmonary disease Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD Year: 2015 Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD: points to ponder Year: 2014 Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease Source: International Congress 2014 – Markers Year: 2014 Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Mechanisms of ECG changes in chronic obstructive pulmonary disease Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Heart rhythm disorders in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – New signalling pathways in COPD Year: 2016